KIF18A-inhibitor treatment showed inhibition of DNA synthesis in both normal cell types that was well above the effective concentration (>20-fold) in sensitive cancer cell lines (Extended Data Fig. 5b,c and Fig. 2e). Here, KIF18A is linked to cancer.